نتایج جستجو برای: quality adjusted life year qaly algorithm

تعداد نتایج: 2563587  

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997
N L Liberato S Quaglini G Barosi

PURPOSE To evaluate the cost-effectiveness of interferon alfa (IFN alpha) treatment of patients with chronic myelogenous leukemia relative to conventional chemotherapy. MATERIALS AND METHODS A decision-analysis model that involved a multistate Markov process was designed to estimate the expected cost and quality-adjusted life expectancies for two cohorts of patients to be administered convent...

Journal: :Annals of internal medicine 2013
Rochelle P Walensky Paul E Sax Yoriko M Nakamura Milton C Weinstein Pamela P Pei Kenneth A Freedberg A David Paltiel Bruce R Schackman

BACKGROUND U.S. HIV treatment guidelines recommend branded once-daily, 1-pill efavirenz-emtricitabine-tenofovir as first-line antiretroviral therapy (ART). With the anticipated approval of generic efavirenz in the United States, a once-daily, 3-pill alternative (generic efavirenz, generic lamivudine, and tenofovir) will decrease cost but may reduce adherence and virologic suppression. OBJECTI...

Background: Although studies reported diabetes mellitus screening cost effective, the mass screening for type2 diabetes remains controversial. In this study we reviewed the recently evidence about the cost effectiveness of mass screening systematically.   Methods: We reviewed the MEDLINE, Scopus, Web of Science (WOS), and Cochrane library databases by MeSH terms to identify relevan...

Journal: :Cost Effectiveness and Resource Allocation : C/E 2008
Kim Dalziel Leonie Segal Duncan Mortimer

BACKGROUND There is an increasing body of published cost-utility analyses of health interventions which we sought to draw together to inform research and policy. METHODS To achieve consistency in costing base and policy context, study scope was limited to Australian-based cost-effectiveness analyses. Through a comprehensive literature review we identified 245 health care interventions that me...

Journal: :Leukemia & lymphoma 2001
D P Wirt F J Giles M M Oken P Solal-Celigny J R Beck

UNLABELLED Recent data from GELF (Groupe d'Etude des Lymphomes Folliculaires) have shown that the addition of interferon alfa-2b (IFN) to a doxorubicin-containing regimen (CHVP: cyclophosphamide, doxorubicin, teniposide and prednisone) prolongs both progression-free survival and overall survival in high-tumor-burden follicular non-Hodgkin's lymphoma. This gain must be weighed against the increm...

Journal: :International journal of technology assessment in health care 1999
J A Scharfstein A D Paltiel M C Weinstein G R Seage E Losina D E Craven K A Freedberg

OBJECTIVE To develop a simulation model to project costs, life expectancy, and cost-effectiveness in discounted dollars per quality-adjusted life-year (QALY) saved for clinical strategies to prevent Mycobacterium avium complex (MAC) in patients with AIDS. METHODS We used natural history data from the Multicenter AIDS Cohort Study, efficacy and toxicity data from randomized clinical trials, an...

2011
Fiona M Clement William A Ghali Stephane Rinfret Braden J Manns

BACKGROUND Increasing population rates of cardiac catheterization can lead to the detection of more people with high risk coronary disease and opportunity for subsequent revascularization. However, such a strategy should only be undertaken if it is cost-effective. METHODS Based on data from a cohort of patients undergoing cardiac catheterization, and efficacy data from clinical trials, we use...

Journal: :Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2010
Roberta Ara John E Brazier

BACKGROUND The methods used to estimate health-state utility values (HSUV) for multiple health conditions can produce very different values. Economic results generated using baselines of perfect health are not comparable with those generated using baselines adjusted to reflect the HSUVs associated with the health condition. Despite this, there is no guidance on the preferred techniques and litt...

Journal: :Journal of the National Cancer Institute 2009
Nicole Mittmann Heather-Jane Au Dongsheng Tu Christopher J O'Callaghan Pierre K Isogai Christos S Karapetis John R Zalcberg William K Evans Malcolm J Moore Jehan Siddiqui Brian Findlay Bruce Colwell John Simes Peter Gibbs Matthew Links Niall C Tebbutt Derek J Jonker

BACKGROUND The National Cancer Institute of Canada Clinical Trials Group CO.17 study showed that patients with advanced colorectal cancer had improved overall survival when cetuximab, an epidermal growth factor receptor-targeting antibody, was given in addition to best supportive care. We conducted a cost-effectiveness analysis using prospectively collected resource utilization and health utili...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید